Mark Mulligan, MD
Enriched profileThomas S. Murphy, Sr. Professor of Medicine; former Director, Division of Infectious Diseases & Immunology and inaugural Director, NYU Langone Vaccine Center (retired from leadership roles effective October 1, 2025) · NYU Grossman School of Medicine
Mark Mulligan is Thomas S. Murphy, Sr. Professor of Medicine; former Director, Division of Infectious Diseases & Immunology and inaugural Director, NYU Langone Vaccine Center (retired from leadership roles effective October 1, 2025) at NYU Grossman School of Medicine. OpenAlex indexes 314 publications with 24,702 citations (h-index 70); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Mark J. Mulligan, MD, is Thomas S. Murphy, Sr. Professor of Medicine at NYU Grossman School of Medicine / NYU Langone Health. The public record shows 314 publications with 24,702 citations (h-index 70), centered on SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, COVID-19 Clinical Research Studies. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (2008–2022).
- Most recent indexed publication: 2025 · Platelets
- Top research focus: SARS-CoV-2 and COVID-19 Research
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 198.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Treating COVID-19 With Hydroxychloroquine (TEACH)
Sponsor: NYU Langone Health
- Immune Memory After Papillomavirus Vaccination
Sponsor: Emory University
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20224 payments
- Merck Sharp & Dohme CorporationProgram year20211 payment
- PFIZER INC.Program year20211 payment
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2008–2022 per NIH RePORTER. The latest:
- Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
New York University School of Medicine
FY2025$249,587UM1AI148574 - Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
New York University School of Medicine
FY2025$46,709UM1AI148574 - Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
New York University School of Medicine
FY2024$804,593UM1AI148574
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response.
Journal of virology
Article2025 - Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
The Pediatric infectious disease journal
Article2024
Most-cited works
by citation count (OpenAlex)- 01Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2,732 citations2020
- 02Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults1,588 citations2020
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/mark-mulligan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗ - X / Twitter
x.com/mjmull
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
X/Twitter handle @mjmull, bio lists "MD, FIDSA"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Board Certified
Internal Medicine, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
Infectious Disease, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Scientific Advisory Board member
Meissa Vaccines
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →businesswire.com ↗
Awards & honors
honors on the public record- FIDSA
Fellow of the Infectious Diseases Society of America
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- Professor
Department of Microbiology, NYU Grossman School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗ - Formerly: Associate Division Director for Clinical and Translational Research
Division of Infectious Diseases, Emory University; Executive Director, Hope Clinic (Emory Vaccine Center clinical arm)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗ - Former lead investigator
NIAID-funded Emory-CDC HIV/AIDS Clinical Trials Unit; former principal investigator, NIH/NIAID Infectious Diseases Clinical Research Consortium (IDCRC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idcrc.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swiny.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jill Buyon, MD
NYU Grossman School of Medicine
Jeffrey Berger, MD
NYU Grossman School of Medicine
David Goldfarb, MD
NYU Grossman School of Medicine
Harmony Reynolds, MD
NYU Grossman School of Medicine